
What are pharmaceutical, biotech, and medical device companies trying to buy with $700,000,000? Massive influence with our government.
That’s the amount of money these companies spent over the last three years lobbying Congress and the Executive Branch, which includes the Food and Drug Administration (FDA). And now, with negotiations underway on legislation that will govern how the FDA approves and monitors prescription drugs and medical products, it’s clear that all that money has bought the industry a lot of influence with our legislators.
We can’t allow science to take a back seat to the financial interests of corporations—especially when our lives are on the line.
We have seen many concerted efforts from industry lobbyists to roll back key safeguards at the FDA that protect science from corporate interference. The FDA’s foremost priority is to protect the American people from unsafe food, drugs, and medical devices. That requires the agency use the best available science when determining whether products are safe or not.
It’s time we remind the FDA to put safety first.
Take Action Today!
Sincerely,
Michael Halpern Program Manager UCS Scientific Integrity Program
P.S. Don’t Forget: Give to the Union of Concerned Scientists today and your gift will go twice as far—helping to challenge attacks on science and stand up to corporate-sponsored misinformation.
You must be logged in to post a comment.